Eltrombopag Added to Standard Immunosuppression in Treatment-Naive Severe Aplastic Anemia
Phase of Trial: Phase I/II
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Antithymocyte globulin (Primary) ; Ciclosporin (Primary) ; Eltrombopag (Primary)
- Indications Anaemia; Aplastic anaemia; Neutropenia; Pancytopenia; Thrombocytopenia
- Focus Adverse reactions; Registrational; Therapeutic Use
- 07 Feb 2018 Planned primary completion date changed from 30 Jan 2018 to 30 Jan 2019.
- 21 Nov 2017 Planned number of patients changed from 150 to 182.
- 20 Apr 2017 Primary endpoint (Rate of complete hematologic response at six months for cohort 3) has been met.